Skip to main content
. 2022 Jun 17;40(35):4060–4070. doi: 10.1200/JCO.22.00668

TABLE 3.

Adverse Events in All 40 Patients With Hepatitis C Virus–Positive Indolent Lymphomas Treated With Direct-Acting Antivirals

graphic file with name jco-40-4060-g005.jpg